{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T05:44:17Z","timestamp":1792734257218,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.jbspin.2007.06.006","type":"journal-article","created":{"date-parts":[[2007,9,4]],"date-time":"2007-09-04T12:42:58Z","timestamp":1188909778000},"page":"116-124","source":"Crossref","is-referenced-by-count":69,"title":["Gaucher disease"],"prefix":"10.1016","volume":"75","author":[{"given":"Pascal","family":"Guggenbuhl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Grosbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rard","family":"Chal\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2007.06.006_bib1","unstructured":"Gaucher P., De l'\u00e9pith\u00e9lioma primitif de la rate (hypertrophie idiopathique de la rate sans leuc\u00e9mie). Th\u00e8se Paris, 1882."},{"issue":"Suppl 3","key":"10.1016\/j.jbspin.2007.06.006_bib2","first-page":"374s","article-title":"Adult Gaucher disease","volume":"22","author":"Stirnemann","year":"2001","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2007.06.006_bib3","series-title":"Gaucher disease","first-page":"321","article-title":"Epidemiology and screening policy","author":"Meikle","year":"2007"},{"key":"10.1016\/j.jbspin.2007.06.006_bib4","series-title":"Gaucher disease","first-page":"97","article-title":"Cellular pathology in Gaucher disease","author":"Futerman","year":"2007"},{"key":"10.1016\/j.jbspin.2007.06.006_bib5","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10545-006-0411-z","article-title":"Glucosylceramide transfer from lysosomes\u2014the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data","volume":"29","author":"Elleder","year":"2006","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jbspin.2007.06.006_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/08035320600619039","article-title":"Gaucher disease: multiple lessons from a single gene disorder","volume":"95","author":"Beutler","year":"2006","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.jbspin.2007.06.006_bib7","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1001\/archinte.160.18.2835","article-title":"The Gaucher registry: demographics and disease characteristics of 1698 patients with Gaucher disease","volume":"160","author":"Charrow","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jbspin.2007.06.006_bib8","first-page":"1076","article-title":"Neurological manifestations of type 1 Gaucher's disease: is a revision of disease classification needed?","volume":"162","author":"Cherin","year":"2006","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jbspin.2007.06.006_bib9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-0223(200001)20:1<60::AID-PD763>3.0.CO;2-R","article-title":"Gaucher disease: considerations in prenatal diagnosis","volume":"20","author":"Grabowski","year":"2000","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.jbspin.2007.06.006_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/01.bor.0000147283.40529.13","article-title":"Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I)","volume":"17","author":"Pastores","year":"2005","journal-title":"Curr Opin Rheumatol"},{"issue":"Suppl 1","key":"10.1016\/j.jbspin.2007.06.006_bib11","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1259\/bjr.75.suppl_1.750002","article-title":"Skeletal aspects of Gaucher disease: a review","volume":"75","author":"Wenstrup","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jbspin.2007.06.006_bib12","doi-asserted-by":"crossref","first-page":"748","DOI":"10.2106\/00004623-200105000-00016","article-title":"Gaucher disease. New approaches to an ancient disease","volume":"83-A","author":"Mankin","year":"2001","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.jbspin.2007.06.006_bib13","series-title":"Diagnosis of bone and joint disorders","article-title":"Gaucher's disease","author":"Resnick","year":"1995"},{"key":"10.1016\/j.jbspin.2007.06.006_bib14","first-page":"201","article-title":"Risk factors for osteonecrosis in patients with type 1 Gaucher's disease","author":"Rodrigue","year":"1999","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.jbspin.2007.06.006_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/clind\/15.5.771","article-title":"Anaerobic osteomyelitis in patients with Gaucher's disease","volume":"15","author":"Finkelstein","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jbspin.2007.06.006_bib16","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1002\/jbmr.5650111125","article-title":"Bone density in Type 1 Gaucher disease","volume":"11","author":"Pastores","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2007.06.006_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s774-002-8444-1","article-title":"Bone ultrasonometry, bone density, and turnover markers in type 1 Gaucher disease","volume":"20","author":"Fiore","year":"2002","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jbspin.2007.06.006_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/bcmd.2001.0479","article-title":"Biochemical markers of bone turnover as tools in the evaluation of skeletal involvement in patients with type 1 Gaucher disease","volume":"28","author":"Drugan","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jbspin.2007.06.006_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00223-001-2072-0","article-title":"Bone marker alterations in patients with type 1 Gaucher disease","volume":"72","author":"Ciana","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jbspin.2007.06.006_bib20","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2006.05978.x","article-title":"Serum levels of osteoprotegerin and osteoprotegerin polymorphisms in Gaucher disease","volume":"133","author":"Magal","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jbspin.2007.06.006_bib21","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1399-0004.2006.00573.x","article-title":"A questionnaire study for 128 patients with Gaucher disease","volume":"69","author":"Mankin","year":"2006","journal-title":"Clin Genet"},{"key":"10.1016\/j.jbspin.2007.06.006_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00197668","article-title":"MR imaging in adults with Gaucher disease type I: evaluation of marrow involvement and disease activity","volume":"22","author":"Hermann","year":"1993","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.jbspin.2007.06.006_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0022-2143(96)90183-3","article-title":"Analysis of the lipids of normal and Gaucher bone marrow","volume":"127","author":"Miller","year":"1996","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jbspin.2007.06.006_bib24","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1148\/radiol.2292020296","article-title":"Quantification of bone involvement in Gaucher disease: MR imaging bone marrow burden score as an alternative to Dixon quantitative chemical shift MR imaging\u2014initial experience","volume":"229","author":"Maas","year":"2003","journal-title":"Radiology"},{"key":"10.1016\/j.jbspin.2007.06.006_bib25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00004728-200209000-00031","article-title":"Vertebra disc ratio as a parameter for bone marrow involvement and its application in Gaucher disease","volume":"26","author":"Vlieger","year":"2002","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.jbspin.2007.06.006_bib26","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1023\/A:1008859420641","article-title":"Quality of life assessment in adults with type 1 Gaucher disease","volume":"8","author":"Masek","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jbspin.2007.06.006_bib27","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0046-8177(99)90092-8","article-title":"Pulmonary pathology in Gaucher's disease","volume":"30","author":"Amir","year":"1999","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jbspin.2007.06.006_bib28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/qjmed\/94.8.407","article-title":"Lung involvement and enzyme replacement therapy in Gaucher's disease","volume":"94","author":"Goitein","year":"2001","journal-title":"Qjm"},{"key":"10.1016\/j.jbspin.2007.06.006_bib29","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1378\/chest.117.6.1821","article-title":"IV epoprostenol in Gaucher's disease","volume":"117","author":"Elstein","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jbspin.2007.06.006_bib30","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1034\/j.1399-0004.2001.590511.x","article-title":"Severe valvular and aortic arch calcification in a patient with Gaucher's disease homozygous for the D409H mutation","volume":"59","author":"George","year":"2001","journal-title":"Clin Genet"},{"key":"10.1016\/j.jbspin.2007.06.006_bib31","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1056\/NEJM199810153391615","article-title":"Cardiac response to enzyme-replacement therapy in Gaucher's disease","volume":"339","author":"Spada","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2007.06.006_bib32","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1056\/NEJM199805143382016","article-title":"Loss of vision in Gaucher's disease and its reversal by enzyme-replacement therapy","volume":"338","author":"Vom Dahl","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2007.06.006_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/1097-0142(19930701)72:1<219::AID-CNCR2820720139>3.0.CO;2-Y","article-title":"Increased risk of cancer in patients with Gaucher disease","volume":"72","author":"Shiran","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jbspin.2007.06.006_bib34","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"De Fost","year":"2006","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jbspin.2007.06.006_bib35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bcmd.2005.03.004","article-title":"Incidence of malignancies among patients with type I Gaucher disease from a single referral clinic","volume":"34","author":"Zimran","year":"2005","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jbspin.2007.06.006_bib36","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and cancer incidence: a study from the Gaucher Registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1016\/j.jbspin.2007.06.006_bib37","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0248-8663(06)80007-X","article-title":"Current and future biochemical markers for Gaucher disease","volume":"27","author":"Froissart","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jbspin.2007.06.006_bib38","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1007\/s00018-006-6269-2","article-title":"Chitotriosidase: the yin and yang","volume":"63","author":"Malaguarnera","year":"2006","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jbspin.2007.06.006_bib39","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/08035320510028094","article-title":"Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases","volume":"94","author":"Aerts","year":"2005","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.jbspin.2007.06.006_bib40","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2014macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2007.06.006_bib41","first-page":"3085","article-title":"Splenectomy in Gaucher disease: new management dilemmas","volume":"91","author":"Krasnewich","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2007.06.006_bib42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1056\/NEJM199709043371015","article-title":"Short-term effects of pamidronate in patients with Gaucher's disease and severe skeletal involvement","volume":"337","author":"Ciana","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2007.06.006_bib43","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1182\/blood-2003-11-3854","article-title":"Gaucher disease: alendronate disodium improves bone mineral density in adults receiving enzyme therapy","volume":"104","author":"Wenstrup","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2007.06.006_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.7326\/0003-4819-122-1-199501010-00005","article-title":"Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources","volume":"122","author":"Grabowski","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jbspin.2007.06.006_bib45","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0002-9343(02)01150-6","article-title":"Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5years of treatment: a report from the Gaucher Registry","volume":"113","author":"Weinreb","year":"2002","journal-title":"Am J Med"},{"issue":"Suppl 1","key":"10.1016\/j.jbspin.2007.06.006_bib46","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1259\/bjr.75.suppl_1.750025","article-title":"Response of Gaucher bone disease to enzyme replacement therapy","volume":"75","author":"Poll","year":"2002","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jbspin.2007.06.006_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ymgme.2006.09.003","article-title":"The long-term international safety experience of imiglucerase therapy for Gaucher disease","volume":"90","author":"Starzyk","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jbspin.2007.06.006_bib48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.GIM.0000153660.88672.3C","article-title":"Individualization of long-term enzyme replacement therapy for Gaucher disease","volume":"7","author":"Andersson","year":"2005","journal-title":"Genet Med"},{"key":"10.1016\/j.jbspin.2007.06.006_bib49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2007-979754","article-title":"Enzyme infusion therapy of the Norrbottnian (type 3) Gaucher disease","volume":"26","author":"Erikson","year":"1995","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jbspin.2007.06.006_bib50","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1067\/mpd.2001.112171","article-title":"The efficacy of enzyme replacement therapy in patients with chronic neuronopathic Gaucher's disease","volume":"138","author":"Altarescu","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.jbspin.2007.06.006_bib51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s004310000630","article-title":"Improvement of neurological symptoms by enzyme replacement therapy for Gaucher disease type IIIb","volume":"160","author":"Aoki","year":"2001","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jbspin.2007.06.006_bib52","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1096-8628(19970711)71:1<16::AID-AJMG3>3.0.CO;2-O","article-title":"Gaucher disease: enzyme therapy in the acute neuronopathic variant","volume":"71","author":"Prows","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.jbspin.2007.06.006_bib53","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/bcmd.2002.0517","article-title":"Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy","volume":"28","author":"Schiffmann","year":"2002","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.jbspin.2007.06.006_bib54","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00774-004-0529-8","article-title":"Bone density changes with enzyme therapy for Gaucher disease","volume":"22","author":"Lebel","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.jbspin.2007.06.006_bib55","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10545-005-0032-y","article-title":"Gaucher disease and bone: laboratory and skeletal mineral density variations during a long period of enzyme replacement therapy","volume":"28","author":"Ciana","year":"2005","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jbspin.2007.06.006_bib56","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1359\/jbmr.061004","article-title":"Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease","volume":"22","author":"Wenstrup","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2007.06.006_bib57","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1023\/B:BOLI.0000045756.54006.17","article-title":"Sustained therapeutic effects of oral miglustat (Zavesca, N-butyldeoxynojirimycin, OGT 918) in type I Gaucher disease","volume":"27","author":"Elstein","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jbspin.2007.06.006_bib58","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1098\/rstb.2003.1272","article-title":"Gaucher disease and the clinical experience with substrate reduction therapy","volume":"358","author":"Zimran","year":"2003","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.jbspin.2007.06.006_bib59_1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/ajh.20504","article-title":"Guidance on the use of miglustat for treating patients with type 1 Gaucher disease","volume":"80","author":"Weinreb","year":"2005","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jbspin.2007.06.006_bib59_2","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2007-02-075960","article-title":"Oral maintenance clinical trial with miglustat for type 1 Gaucher disease: switch from or combination with intravenous enzyme replacement","author":"Elsteinb","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jbspin.2007.06.006_bib60","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/cbic.200390045","article-title":"Chemical chaperones-a new concept in drug research","volume":"4","author":"Kolter","year":"2003","journal-title":"Chembiochem"},{"key":"10.1016\/j.jbspin.2007.06.006_bib61","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S beta-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jbspin.2007.06.006_bib62","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.chembiol.2005.09.007","article-title":"Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles","volume":"12","author":"Sawkar","year":"2005","journal-title":"Chem Biol"},{"key":"10.1016\/j.jbspin.2007.06.006_bib63","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/jgm.732","article-title":"Long-term expression of the human glucocerebrosidase gene in vivo after transplantation of bone-marrow-derived cells transformed with a lentivirus vector","volume":"7","author":"Kim","year":"2005","journal-title":"J Gene Med"},{"key":"10.1016\/j.jbspin.2007.06.006_bib64","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1517\/14712598.1.5.857","article-title":"Gene therapy for lysosomal storage disorders","volume":"1","author":"Barranger","year":"2001","journal-title":"Expert Opin Biol Ther"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X07002813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X07002813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,17]],"date-time":"2024-02-17T18:54:19Z","timestamp":1708196059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X07002813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S1297319X07002813"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2007.06.006","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}